Etat des chemins et routes les plus praticables pour entrer dans la vallée et chateau de Queyras, et les differents cols par ou l'on peut penetrer dans les Etats du Roy de Sardaigne dans le Piedmont

Ancien possesseur : Argenson, Antoine-René de Voyer (1722-1787 ; marquis de Paulmy d')

Entre communauté civique et communauté hellénique. Theôria l'hétaïre dans la «Paix» d'Aristophane

This paper investigates practices connected with the institution of theôria, before focusing on semantic values conveyed by the figure of Theôria in Aristophanes' Peace. The analysis shows how the languages of sacrifice, athletism and sexuality are used metaphorically in the description of Theôria; her description as a hetaira is especially significant since it highlights civic and panhellenic ties which are at stake in the institution of theôria.

L'utilisation de l'Evangile de Thomas dans la recherche actuelle sur les paroles de Jésus

(Résumé de l'ouvrage) Ce volume regroupe des travaux menés sur le Jésus de l'histoire par des spécialistes de cette question fondatrice. Celle-ci connait, en effet, de vigoureuses impulsions dues à l'application de nouvelles méthodologies aux effets inattendus: sociologie du judaisme ancien, anthropologie des sociétés agraires, utilisation des écrits apocryphes chrétiens. Pour la première fois, des savants mondialement réputés sont présentés en français tels John S. Kloppenborg (Toronto) ou Ed P. Sanders (Durham). L'ouvrage est construit en sept parties: l'état de la recherche, le judaisme au temps de Jésus, le coeur de la théologie de Jésus, la tradition extracanonique chrétienne et la question du Jésus historique, Jésus dans le Nouveau Testament, les lectures juives de Jésus, le Jésus historique et la théologie.

Expertises croisées dans la dégénérescence maculaire liée à l'âge. Focus sur la physiopathologie, l'angiogenèse, les données pharmacologiques et cliniques [Review and expert opinion in age related macular degeneration. Focus on the pathophysiology, angiogenesis and pharmacological and clinical data].

Age related macular degeneration (AMD) is a pathological aging of the macula, brought about by the interaction of genetic and environmental factors. It induces geographic atrophy of the retina and/or choroidal neovascularization. In the latter, abnormal vessels develop from the choriocapillaris, with the involvement of VEGF (vascular endothelial growth factor). The VEGF family includes several factors, including VEGF-A, B, C, D, F and PlGF (placental growth factor). Their biological properties and their affinities to the VEGFR1, VEGFR2 and VEGFR3 receptors found on endothelial cells differ. Exudative AMD involves mainly VEGF-A and VEGF-R2. Anti-VEGF agents used in ophthalmology (ranibizumab, bevacizumab and aflibercept) are designed to primarily target this pathway. In vitro, all have sufficient affinity to their ligands. Their therapeutic efficacy must therefore be judged based on clinical criteria. In clinical practice, the minimum number of injections required for a satisfactory result appears to be comparable with all the three. The few available studies on therapeutic substitutions of anti-VEGF compounds suggest that some patients may benefit from substituting the anti-VEGF in cases of an unsatisfactory response to an initial molecule. Although local side effects, including increased risk of geographic atrophy, and systemic effects, including vascular accidents, have been suggested, these risks remain low, specially compared to the benefits of the treatment. Differences in safety between anti-VEGF are theoretically possible but unproven.